The size of the European Nucleic Acid Labelling Market was worth USD 424.11 Million in 2020. It is further estimated to be growing at a CAGR of 8.25% and worth USD 630.4 Million by 2025.
Nucleic Acid Labelling has many applications in the fields of drug discovery and identification of new diseases.
Our genetic information is carried forward to next-generation by nucleic acids, which are large complex molecules. Two major types of them are DNA and RNA. They are labeled with tags that help in detection and purification. One of the labeling techniques is Random Priming. A marked counterpart is synthesized on denatured (single-stranded) DNA using short primers as the starting point. Due to the short strands to be synthesized, this system is simple and fast. Labeling has numerous applications in drug discovery and disease identification.
Major factors accountable for the market's growth are increasing demand for personalized healthcare, increasing expenditure for health care, and increasing funding for R&D in genomics and disease diagnosis.
Yet, factors like expensive processing techniques and lack of skilled professionals are likely to confine the market's growth.
This research report on the European Nucleic Acid Labelling Market has been segmented and sub-segmented into the following categories:
By Product:
By Labelling Technique:
By Application:
By End Users:
By Country:
Notable companies dominating the European Nucleic Acid Labelling Market include Thermo Fisher Scientific, New England Biolabs, PerkinElmer, F. Hoffmann La-Roche AG, General Electric Company, Merck KGaA, Enzo Biochem, Promega Corporation, Vector Laboratories, and Agilent Technologies.
1.Introduction
1.1 Market Definition
1.2 Study Deliverables
1.3 Base Currency, Base Year and Forecast Periods
1.4 General Study Assumptions
2. Research Methodology
2.1 Introduction
2.2 Research Phases
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Econometric Modelling
2.2.4 Expert Validation
2.3 Analysis Design
2.4 Study Timeline
3. Overview
3.1 Executive Summary
3.2 Key Inferences
3.3 Epidemology
4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
4.1 Market Drivers
4.2 Market Restraints
4.3 Key Challenges
4.4 Current Opportunities in the Market
5. Market Segmentation
5.1 Product
5.1.1 Introduction
5.1.2 Reagents and Kits
5.1.2.1 Labels
5.1.2.1.1 Radioactive Labels
5.1.2.1.2 Non-Radioactive Labels
5.1.2.2 Probes
5.1.2.2.1 Radioactive Probes
5.1.2.2.2 Non-Radioactive Probes
5.1.3 Services
5.1.4 Y-o-Y Growth Analysis, By Product
5.1.5 Market Attractiveness Analysis, By Product
5.1.6 Market Share Analysis, By Product
5.2 Labelling Technique
5.2.1 Introduction
5.2.2 PCR
5.2.3 Nick Translation
5.2.4 Random Primer
5.2.5 In-Vitro Transcription
5.2.6 Reverse Transcription
5.2.7 End Labelling
5.2.8 Y-o-Y Growth Analysis, By Labelling Technique
5.2.9 Market Attractiveness Analysis, By Labelling Technique
5.2.10 Market Share Analysis, By Labelling Technique
5.3 Application
5.3.1 Introduction
5.3.2 DNA Sequencing
5.3.3 Polymerase Chain Reaction
5.3.4 Fluorescence in Situ Hybridization (FISH)
5.3.5 Microarrays
5.3.6 Blotting
5.3.7 In-Situ Hybridization
5.3.8 Other Applications
5.3.9 Y-o-Y Growth Analysis, By Application
5.3.10 Market Attractiveness Analysis, By Application
5.3.11 Market Share Analysis, By Application
5.4 End-Users
5.4.1 Introduction
5.4.2 Diagnostic Centres
5.4.3 Research Centres
5.4.4 Hospitals
5.4.5 Y-o-Y Growth Analysis, By End-Users
5.4.6 Market Attractiveness Analysis, By End-Users
5.4.7 Market Share Analysis, By End-Users
6. Geographical Analysis
6.1 Introduction
6.1.1 Regional Trends
6.1.2 Impact Analysis
6.1.3 Y-o-Y Growth Analysis
6.1.3.1 By Geographical Area
6.1.3.2 By Product
6.1.3.3 By Labelling Technique
6.1.3.4 By Application
6.1.3.5 By End-Users
6.1.4 Market Attractiveness Analysis
6.1.4.1 By Geographical Area
6.1.4.2 By Product
6.1.4.3 By Labelling Technique
6.1.4.4 By Application
6.1.4.5 By End-Users
6.1.5 Market Share Analysis
6.1.5.1 By Geographical Area
6.1.5.2 By Product
6.1.5.3 By Labelling Technique
6.1.5.4 By Application
6.1.5.5 By End-Users
6.2 U.K
6.3 Spain
6.4 Germany
6.5 Italy
6.6 France
7.Strategic Analysis
7.1 PESTLE analysis
7.1.1 Political
7.1.2 Economic
7.1.3 Social
7.1.4 Technological
7.1.5 Legal
7.1.6 Environmental
7.2 Porter’s Five analysis
7.2.1 Bargaining Power of Suppliers
7.2.2 Bargaining Power of Consumers
7.2.3 Threat of New Entrants
7.2.4 Threat of Substitute Products and Services
7.2.5 Competitive Rivalry within the Industry
8.Market Leaders' Analysis
8.1 Thermo Fisher Scientific
8.1.1 Overview
8.1.2 Product Analysis
8.1.3 Financial analysis
8.1.4 Recent Developments
8.1.5 SWOT analysis
8.1.6 Analyst View
8.2 New England Biolabs
8.3 PerkinElmer
8.4 F.Hoffmann La-Roche AG
8.5 General Electric Company
8.6 Merck KGaA
8.7 Enzo Biochem
8.8 Promega Corporation
8.9 Vector Laboratories
8.10 Agilent Technologies
9.Competitive Landscape
9.1 Market share analysis
9.2 Merger and Acquisition Analysis
9.3 Agreements, collaborations and Joint Ventures
9.4 New Product Launches
10.Market Outlook and Investment Opportunities
Appendix
a) List of Tables
b) List of Figures
Related Reports
